Related Experiment Videos
Summary
This case highlights a rare association between ocular reticulum cell sarcoma (RCS) and central nervous system (CNS) RCS. It suggests that low-dose immunosuppressive therapy may be harmful in patients with RCS.
Area of Science:
- Ophthalmology
- Oncology
- Neurology
Background:
- Recalcitrant uveitis can be a challenging clinical presentation.
- Reticulum cell sarcoma (RCS), a type of non-Hodgkin lymphoma, can affect various parts of the body, including the central nervous system (CNS) and the eye.
Observation:
- A 57-year-old woman presented with persistent uveitis.
- She was diagnosed with CNS reticulum cell sarcoma (RCS) which responded to radiotherapy.
- After cataract surgery, her uveitis recurred and worsened, with suspected ocular RCS.
- Iris nodular thickening led to azathioprine treatment, during which the lesion enlarged, revealing extensive ocular RCS.
Findings:
- The case demonstrated an exceptional association between uveal tract and CNS reticulum cell sarcoma (RCS).
- Ocular RCS was confirmed after initial non-diagnostic aqueous aspirates.
- The patient's condition progressed despite suspected ocular RCS, and azathioprine treatment coincided with lesion enlargement.
Implications:
- This case underscores the potential link between ocular and CNS reticulum cell sarcoma (RCS).
- It suggests that low-dose immunosuppressive agents may be detrimental in the management of RCS.
- Further research is warranted to understand the interplay between immunosuppression and RCS progression.